Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  He, Shi Ming ^a   Zhao, Zhen Wei ^a   Wang, Yuan ^a   Zhao, Ji Pei ^a   Wang, Liang ^a   Hou, Fang ^a   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

glioma; Immunochemistry assay; prognosis; Quantitative real time PCR; SMAD4; Western blot analysis

Indexed keywords

SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOMA; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; WESTERN BLOTTING; BIOSYNTHESIS; CASE CONTROL STUDY; DISEASE COURSE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SMAD4 PROTEIN; SURVIVAL RATE;

EID: 79960672486     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-70     Document Type: Article

References (21)

1. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma. Li X, Wang L, Gu JW, Li B, Liu WP, Wang YG, Zhang X, Zhen HN, Fei Z, Tumour Biol 2010 31 477 488 10.1007/s13277-010-0060-6 20571968
2. Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. Sun B, Chu D, Li W, Chu X, Li Y, Wei D, Li H, J Neurooncol 2009 94 213 219 10.1007/s11060-009-9859-7 19337694
3. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Zheng H, Stegh AH, Scott KL, Signoretti S, Bardeesy N, Wang YA, Hill DE, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA, Nature 2011 470 269 273 10.1038/nature09677 21289624
4. Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells. Ali NA, McKay MJ, Molloy MP, Mol Biosyst 2010 6 2332 2338 10.1039/c0mb00016g 20862427
5. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, Abdolmaleky HM, Zhou JR, Thiagalingam S, Cancer Res 2011 71 998 1008 10.1158/0008-5472.CAN-09- 3269 21245094
6. Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer. Sakellariou S, Liakakos T, Ghiconti I, Hadjikokolis S, Nakopoulou L, Pavlakis K, Anticancer Res 2008 28 1079 1083 18507057 (Pubitemid 351578957)
7. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RH, Clin Cancer Res 2009 15 4674 4679 10.1158/1078-0432.CCR-09-0227 19584151
8. Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non-small cell lung cancer. Ke Z, Zhang X, Ma L, Wang L, Hum Pathol 2008 39 1438 1445 10.1016/j.humpath.2008.03.006 18620728
9. Association of -catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L, Li SQ, Med Oncol 2011
10. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas. Sheehan GM, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Ross JS, Hum Pathol 2005 36 1204 1209 10.1016/j.humpath.2005.08. 015 16260274 (Pubitemid 41540397)
11. Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma. Hiwatashi K, Ueno S, Sakoda M, Kubo F, Tateno T, Kurahara H, Mataki Y, Maemura K, Ishigami S, Shinchi H, Natsugoe S, Ann Surg Oncol 2009 16 3176 3182 10.1245/s10434-009-0614-2 19626374
12. Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study. Brown RS, Wahl RL, Cancer 1993 72 2979 2985 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X 8221565 (Pubitemid 23335044)
13. Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Mesker WE, Liefers GJ, Junggeburt JM, van Pelt GW, Alberici P, Kuppen PJ, Miranda NF, van Leeuwen KA, Morreau H, Szuhai K, Tollenaar RA, Tanke HJ, Cell Oncol 2009 31 169 178 19478385
14. Promoter-wide analysis of Smad4 binding sites in human epithelial cells. Koinuma D, Tsutsumi S, Kamimura N, Imamura T, Aburatani H, Miyazono K, Cancer Sci 2009 100 2133 2142 10.1111/j.1349-7006.2009.01299.x 19686287
15. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. Bornstein S, White R, Malkoski S, Oka M, Han G, Cleaver T, Reh D, Andersen P, Gross N, Olson S, Deng C, Lu SL, Wang XJ, J Clin Invest 2009 119 3408 3419 19841536
16. Smad4: gatekeeper gene in head and neck squamous cell carcinoma. Korc M, J Clin Invest 2009 119 3208 3211 19841540
17. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Wilentz RE, Su GH, Dai JL, Sparks AB, Argani P, Sohn TA, Yeo CJ, Kern SE, Hruban RH, Am J Pathol 2000 156 37 43 10.1016/S0002-9440(10)64703-7 10623651 (Pubitemid 30644436)
18. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH, Cancer Res 2000 60 2002 2006 10766191 (Pubitemid 30207663)
19. Smad4 and Transforming Growth Factor beta1 Expression in Patients with Squamous Cell Carcinoma of the Esophagus. Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T, Clin Cancer Res 2002 8 1838 1842 12060625 (Pubitemid 34633743)
20. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Cardillo MR, Lazzereschi D, Gandini O, Di Silverio F, Colletta G, Anal Quant Cytol Histol 2001 23 109 117 11332076 (Pubitemid 32378082)
21. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Kjellman C, Olofsson SP, Hansson O, Von Schantz T, Lindvall M, Nilsson I, Salford LG, Sjögren HO, Widegren B, Int J Cancer 2000 89 251 258 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0. CO;2-5 10861501 (Pubitemid 30430741)